IMP: Approving the share issuance to increase charter capital

Approving the share issuance to increase charter capital of Imexpharm Corporation as follows:

HOSE

>   MHC: Approving the share issuance for 2023 stock dividend payment (14/08/2024)

>   PPT: Notice on the share issuance (14/08/2024)

>   BCG122006: Report on the results of the share issuance to increase share capital (14/08/2024)

>   TLD: Report on using capital from the share issuance (13/08/2024)

>   PJT: Approval for result of the share issuance to pay dividend (13/08/2024)

>   BCM: Contribution capital increase (13/08/2024)

>   TRS: Report on the results of the share issuance for dividend payment in 2023 (13/08/2024)

>   HPT: Notice on share issue under ESOP (13/08/2024)

>   TRS: Report on the results of the share issuance to pay dividends in 2023 (13/08/2024)

>   SEA: HDCapital is no longer principal shareholder (13/08/2024)